Abstract |
Curcumin is a phytochemical which exhibits significant inhibitory effect in multiple cancers including prostate cancer. MicroRNA-34a (miR-34a) was found to be a master tumor suppressor miRNA and regulated the growth of cancer cells. To date, however, the role of miR-34a in the anticancer action of curcumin against prostate cancer has been rarely reported. In the present study, we showed that curcumin altered the expression of cell cycle-related genes (cyclin D1, PCNA, and p21) and inhibited the proliferation of prostate cancer cells. Furthermore, we found that curcumin significantly upregulated the expression of miR-34a, along with the downregulated expression of β- catenin and c-myc in three prostate cancer cell lines. Inhibition of miR-34a activated β- catenin/c-myc axis, altered cell cycle-related genes expression and significantly suppressed the antiproliferation effect of curcumin in prostate cancer cells. Findings from this study revealed that miR-34a plays an important role in the antiproliferation effect of curcumin in prostate cancer.
|
Authors | Mingming Zhu, Zongmei Zheng, Jiaming Huang, Xiao Ma, Cong Huang, Rui Wu, Xiaoting Li, Zhaofeng Liang, Feifei Deng, Jieshu Wu, Shanshan Geng, Chunfeng Xie, Caiyun Zhong |
Journal | Journal of cellular biochemistry
(J Cell Biochem)
Vol. 120
Issue 9
Pg. 15616-15624
(09 2019)
ISSN: 1097-4644 [Electronic] United States |
PMID | 31042325
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Copyright | © 2019 Wiley Periodicals, Inc. |
Chemical References |
- MIRN34 microRNA, human
- MicroRNAs
- Curcumin
|
Topics |
- Animals
- Cell Line, Tumor
- Cell Proliferation
(drug effects)
- Curcumin
(pharmacology)
- Gene Expression Regulation, Neoplastic
(drug effects)
- Humans
- Male
- Mice
- MicroRNAs
(genetics)
- Prostate
(drug effects, pathology)
- Prostatic Neoplasms
(drug therapy, genetics, pathology)
- Xenograft Model Antitumor Assays
|